本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pandion Therapeutics Inc.

60.05
0.0000
成交量:- -
成交額:- -
市值:17.04億
市盈率:-18.92
高:60.05
開:60.05
低:60.05
收:60.05
資料載入中...
2021/05/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/02

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/04/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/04/01

重要事件披露

8-K - Current report
2021/04/01

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/03/31

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

重要事件披露

8-K - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]